Shares of Zomedica (NYSEMKT: ZOM) were sinking 14.8% lower for the week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter results after the market close on Nov. 12.
The veterinary health company reported revenue in the third quarter of only $22,514. It posted a net loss of $6.3 million, or $0.091 per share. Click to read more on this article and Zomedica Forecast for 2022 at Barron’s News, and stay informed on new developments.
